Why are GLP 1 agonists being used to treat patients with nonalcoholic fatty liver disease? AASLD BPC 157 Peptide: Insights into Digestive Science and Beyond eskNoviny.cz Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: Diclofenac induced gastrointestinal, liver, and encephalopathy lesions ScienceDirect Pentadecapeptide BPC 157 efficiently reduces radiation induced liver injury and lipid accumulation through Kruppel like factor 4 upregulation both in vivo and in vitro ScienceDirect